Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$16.07 - $31.84 $1.63 Million - $3.23 Million
-101,525 Reduced 49.65%
102,944 $2.97 Million
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $2.81 Million - $4.41 Million
163,958 Added 404.72%
204,469 $4.22 Million
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $697,400 - $953,351
-32,317 Reduced 44.37%
40,511 $1.1 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $1.52 Million - $2.35 Million
-58,743 Reduced 44.65%
72,828 $2.16 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $1.92 Million - $3.49 Million
91,841 Added 231.16%
131,571 $4.71 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $910,611 - $1.34 Million
39,730 New
39,730 $931,000
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $53.2 Million - $74.3 Million
1,218,364 Added 1611.55%
1,293,966 $69.7 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $1.08 Million - $2.91 Million
37,565 Added 98.76%
75,602 $3.05 Million
Q1 2022

May 16, 2022

BUY
$48.25 - $100.49 $460,739 - $959,579
9,549 Added 33.52%
38,037 $2.52 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $947,067 - $1.29 Million
10,676 Added 59.94%
28,488 $2.85 Million
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $1.76 Million - $2.35 Million
17,812 New
17,812 $2.23 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.17B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.